{"id":48689,"date":"2022-09-22T13:01:54","date_gmt":"2022-09-22T11:01:54","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/endpoints-news-announces-the-11-most-promising-biotech-startups-of-2022\/"},"modified":"2022-09-22T13:01:54","modified_gmt":"2022-09-22T11:01:54","slug":"endpoints-news-announces-the-11-most-promising-biotech-startups-of-2022","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/endpoints-news-announces-the-11-most-promising-biotech-startups-of-2022\/","title":{"rendered":"Endpoints News Announces the 11 Most Promising Biotech Startups of 2022"},"content":{"rendered":"<div>\n<p>LAWRENCE, Kan.&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/hashtag\/Endpoints11?src=hash\" target=\"_blank\" rel=\"noopener\">#Endpoints11<\/a>&#8212;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fendpts.com%2F&amp;esheet=52921531&amp;newsitemid=20220922005034&amp;lan=en-US&amp;anchor=Endpoints+News&amp;index=1&amp;md5=e9815a309d2253857facfd8071b3b398\" rel=\"nofollow noopener\" shape=\"rect\">Endpoints News<\/a>, the biopharma industry\u2019s leading source for daily news and analysis, today unveiled the <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Feleven22.endpts.com%2F&amp;esheet=52921531&amp;newsitemid=20220922005034&amp;lan=en-US&amp;anchor=2022+Endpoints+11&amp;index=2&amp;md5=90e7d21b17106d95943f2bb91520e3cf\" rel=\"nofollow noopener\" shape=\"rect\">2022 Endpoints 11<\/a> \u2014 the most promising biotech startup companies of the year.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220922005034\/en\/1578166\/5\/EndpointsNews_logo_%283%29.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220922005034\/en\/1578166\/21\/EndpointsNews_logo_%283%29.jpg\"><\/a><\/p>\n<p>\nBorn during a boom but virtually shunned on Wall Street today, this group of upstarts is out to defy some tough odds in birthing a biotech. This year\u2019s list of Endpoints 11 winners is comprised of companies most likely to make their mark \u2014 or go down fighting for a landmark change.\n<\/p>\n<p>\n&#8220;I&#8217;ve been picking top biotech startups for 20 years now, and every year&#8217;s class of standouts is different in its own way. This group faces some unusual challenges,\u201d said John Carroll, founder and editor of Endpoints News. \u201cBut they all have substantial resources, top talent and plans to tackle some of the biggest challenges in biotech. They may not all make it \u2014 that doesn&#8217;t happen often \u2014 but their ambitions define the industry today. And that&#8217;s what the Endpoints 11 is all about.\u201d\n<\/p>\n<p>\nThe 2022 Endpoints 11 winners are:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nAffini-T\n<\/li>\n<li>\nAltos Labs\n<\/li>\n<li>\nAreteia Therapeutics\n<\/li>\n<li>\nGenerate Biomedicines\n<\/li>\n<li>\nMammoth Biosciences\n<\/li>\n<li>\nMetagenomi\n<\/li>\n<li>\nNeumora Therapeutics\n<\/li>\n<li>\nOdyssey Therapeutics\n<\/li>\n<li>\nOrna Therapeutics\n<\/li>\n<li>\nRome Therapeutics\n<\/li>\n<li>\nVersanis Bio\n<\/li>\n<\/ul>\n<p>\nThe 2022 Endpoints 11 will be hosted live at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fthe105bybreakthrough.com%2F&amp;esheet=52921531&amp;newsitemid=20220922005034&amp;lan=en-US&amp;anchor=The+105&amp;index=3&amp;md5=74bfdd534faed0c56470f186b36f80d8\" rel=\"nofollow noopener\" shape=\"rect\">The 105<\/a> in Boston with an open bar and networking beginning at 6 pm ET. At 7 pm ET, Carroll will visit with Nobel Prize laureate and biotech legend Phillip Sharp in an exclusive fireside chat. \u201cSharp was present at the creation of the biotech industry, which has blossomed into a global endeavor that\u2019s seen investors pile in as startups tackled some of the biggest challenges in drug hunting,\u201d said Carroll.\n<\/p>\n<p>\nAt 7:30 pm ET, Alessandro Maselli, President &amp; CEO at Catalent, will present the awards alongside Carroll. Attendees will also see exclusive footage of Carroll talking biotech with the teams behind the Endpoints 11. The event is sponsored by Catalent, Egnyte and Precision ADVANCE, the cell &amp; gene therapy collective and will be live-streamed to registrants from 7 to 8:15 pm ET.\n<\/p>\n<p>\nThis marks John Carroll\u2019s 20th year selecting top private biotechs for special recognition. Registration is open to all biopharma professionals at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Feleven22.endpts.com%2F&amp;esheet=52921531&amp;newsitemid=20220922005034&amp;lan=en-US&amp;anchor=eleven22.endpts.com&amp;index=4&amp;md5=f030ba4a4e46d6a5ae07c98ca38d1a91\" rel=\"nofollow noopener\" shape=\"rect\">eleven22.endpts.com<\/a>. <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.tickettailor.com%2Fevents%2Fendpointsnews%2F742452&amp;esheet=52921531&amp;newsitemid=20220922005034&amp;lan=en-US&amp;anchor=Ticket+sales&amp;index=5&amp;md5=a6641657b932585adffc781c605271a0\" rel=\"nofollow noopener\" shape=\"rect\">Ticket sales<\/a> for the live event will close at 4 pm ET today. The web feature with profiles on each company is available to Endpoints readers with a premium subscription at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.endpts.com&amp;esheet=52921531&amp;newsitemid=20220922005034&amp;lan=en-US&amp;anchor=www.endpts.com&amp;index=6&amp;md5=6ae3d3b0722da04b9c04f515300d2822\" rel=\"nofollow noopener\" shape=\"rect\">www.endpts.com<\/a>.\n<\/p>\n<p>\nAbout Endpoints News\n<\/p>\n<p>\nEndpoints News is an independent media company covering the most influential developments across the life sciences industry. Founded in 2016 by award-winning editor John Carroll and publisher Arsalan Arif, the publication has attracted a global team of more than 40 writers and media professionals, delivering readers the critical insights they need, when they need them the most. Breaking news, industry analysis and in-depth journalism are delivered daily through the industry\u2019s most comprehensive news reports. The top destination for life sciences news, Endpoints is read by key decision-makers changing the future of healthcare. With a growing readership of 150,000 subscribers, Endpoints News has earned more than 4 million page views a month, with around 1 million readers that include leaders from the most innovative startups to the top 25 large pharma companies. Endpoints News is a virtual company with corporate headquarters in Lawrence, Kansas. For more information, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.endpts.com&amp;esheet=52921531&amp;newsitemid=20220922005034&amp;lan=en-US&amp;anchor=www.endpts.com&amp;index=7&amp;md5=f6900a058a5b1eb4f6ff61cadcb1dfea\" rel=\"nofollow noopener\" shape=\"rect\">www.endpts.com<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nMedia:<br \/>\n<br \/>Amanda Florez<br \/>\n<br \/>Endpoints News<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;i&#x6c;&#x74;&#111;&#x3a;a&#x66;&#x6c;&#111;&#x72;e&#x7a;&#x40;&#101;&#x6e;d&#x70;&#x6f;&#105;&#x6e;t&#x73;&#x6e;&#101;&#x77;s&#x2e;&#x63;&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">a&#102;&#x6c;&#x6f;&#x72;e&#122;&#64;&#x65;&#x6e;d&#112;&#111;&#x69;&#x6e;ts&#110;&#x65;&#x77;&#x73;&#46;&#99;&#x6f;&#x6d;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>LAWRENCE, Kan.&#8211;(BUSINESS WIRE)&#8211;#Endpoints11&#8212;Endpoints News, the biopharma industry\u2019s leading source for daily news and analysis, today unveiled the 2022 Endpoints 11 \u2014 the most promising biotech startup companies of the year. Born during a boom but virtually shunned on Wall Street today, this group of upstarts is out to defy some tough odds in birthing a &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/endpoints-news-announces-the-11-most-promising-biotech-startups-of-2022\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48689","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Endpoints News Announces the 11 Most Promising Biotech Startups of 2022 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/endpoints-news-announces-the-11-most-promising-biotech-startups-of-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Endpoints News Announces the 11 Most Promising Biotech Startups of 2022 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LAWRENCE, Kan.&#8211;(BUSINESS WIRE)&#8211;#Endpoints11&#8212;Endpoints News, the biopharma industry\u2019s leading source for daily news and analysis, today unveiled the 2022 Endpoints 11 \u2014 the most promising biotech startup companies of the year. Born during a boom but virtually shunned on Wall Street today, this group of upstarts is out to defy some tough odds in birthing a ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/endpoints-news-announces-the-11-most-promising-biotech-startups-of-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-22T11:01:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220922005034\/en\/1578166\/21\/EndpointsNews_logo_%283%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endpoints-news-announces-the-11-most-promising-biotech-startups-of-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endpoints-news-announces-the-11-most-promising-biotech-startups-of-2022\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Endpoints News Announces the 11 Most Promising Biotech Startups of 2022\",\"datePublished\":\"2022-09-22T11:01:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endpoints-news-announces-the-11-most-promising-biotech-startups-of-2022\\\/\"},\"wordCount\":550,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endpoints-news-announces-the-11-most-promising-biotech-startups-of-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220922005034\\\/en\\\/1578166\\\/21\\\/EndpointsNews_logo_%283%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endpoints-news-announces-the-11-most-promising-biotech-startups-of-2022\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endpoints-news-announces-the-11-most-promising-biotech-startups-of-2022\\\/\",\"name\":\"Endpoints News Announces the 11 Most Promising Biotech Startups of 2022 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endpoints-news-announces-the-11-most-promising-biotech-startups-of-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endpoints-news-announces-the-11-most-promising-biotech-startups-of-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220922005034\\\/en\\\/1578166\\\/21\\\/EndpointsNews_logo_%283%29.jpg\",\"datePublished\":\"2022-09-22T11:01:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endpoints-news-announces-the-11-most-promising-biotech-startups-of-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endpoints-news-announces-the-11-most-promising-biotech-startups-of-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endpoints-news-announces-the-11-most-promising-biotech-startups-of-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220922005034\\\/en\\\/1578166\\\/21\\\/EndpointsNews_logo_%283%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220922005034\\\/en\\\/1578166\\\/21\\\/EndpointsNews_logo_%283%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endpoints-news-announces-the-11-most-promising-biotech-startups-of-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Endpoints News Announces the 11 Most Promising Biotech Startups of 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Endpoints News Announces the 11 Most Promising Biotech Startups of 2022 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/endpoints-news-announces-the-11-most-promising-biotech-startups-of-2022\/","og_locale":"en_US","og_type":"article","og_title":"Endpoints News Announces the 11 Most Promising Biotech Startups of 2022 - Pharma Trend","og_description":"LAWRENCE, Kan.&#8211;(BUSINESS WIRE)&#8211;#Endpoints11&#8212;Endpoints News, the biopharma industry\u2019s leading source for daily news and analysis, today unveiled the 2022 Endpoints 11 \u2014 the most promising biotech startup companies of the year. Born during a boom but virtually shunned on Wall Street today, this group of upstarts is out to defy some tough odds in birthing a ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/endpoints-news-announces-the-11-most-promising-biotech-startups-of-2022\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-22T11:01:54+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220922005034\/en\/1578166\/21\/EndpointsNews_logo_%283%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/endpoints-news-announces-the-11-most-promising-biotech-startups-of-2022\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/endpoints-news-announces-the-11-most-promising-biotech-startups-of-2022\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Endpoints News Announces the 11 Most Promising Biotech Startups of 2022","datePublished":"2022-09-22T11:01:54+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/endpoints-news-announces-the-11-most-promising-biotech-startups-of-2022\/"},"wordCount":550,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/endpoints-news-announces-the-11-most-promising-biotech-startups-of-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220922005034\/en\/1578166\/21\/EndpointsNews_logo_%283%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/endpoints-news-announces-the-11-most-promising-biotech-startups-of-2022\/","url":"https:\/\/pharma-trend.com\/en\/endpoints-news-announces-the-11-most-promising-biotech-startups-of-2022\/","name":"Endpoints News Announces the 11 Most Promising Biotech Startups of 2022 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/endpoints-news-announces-the-11-most-promising-biotech-startups-of-2022\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/endpoints-news-announces-the-11-most-promising-biotech-startups-of-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220922005034\/en\/1578166\/21\/EndpointsNews_logo_%283%29.jpg","datePublished":"2022-09-22T11:01:54+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/endpoints-news-announces-the-11-most-promising-biotech-startups-of-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/endpoints-news-announces-the-11-most-promising-biotech-startups-of-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/endpoints-news-announces-the-11-most-promising-biotech-startups-of-2022\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220922005034\/en\/1578166\/21\/EndpointsNews_logo_%283%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220922005034\/en\/1578166\/21\/EndpointsNews_logo_%283%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/endpoints-news-announces-the-11-most-promising-biotech-startups-of-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Endpoints News Announces the 11 Most Promising Biotech Startups of 2022"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48689","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48689"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48689\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48689"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48689"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48689"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}